Help Keep This Site Up and Running

Help keep this site bring everyone up to date BioPharma News for Free. Any donations made help keep this site free.  It only takes a second. Thanks For Your Continued Support. Again thank you as I am entering my Second Year of providing BioPharma Stock updates and advice.

Related articles by Zemanta

• What If You Could Click A Button And A Sponsor Would Pay A Site Money (Without It Being Clickfraud)? (techdirt.com)
• 5 Effective Ways to Maximize Ad Revenue on Your Blog (quickonlinetips.com)
• Get Click-By-Click Insight Into Your Site Visitors With MouseTrace (readwriteweb.com)

Bristol-Myers Acquires ZymoGenetics

Image via Wikipedia Healthcare Sector Breaking News for Tuesday, September 07, 2010

Bristol-Myers Squib to merge with ZymoGenetics

After the bell Tuesday, Bristol-Myers Squibb Company (NYSE:BMY) and ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.